Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Olema Pharmaceuticals (OLMA) Insider Trading & Ownership

Olema Pharmaceuticals logo
$5.46 -0.06 (-1.09%)
Closing price 04:00 PM Eastern
Extended Trading
$5.44 -0.02 (-0.37%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.36%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.73M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$5.41M
Get OLMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OLMA Insider Buying and Selling by Quarter

Olema Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/8/2025Bain Capital Life Sciences InvMajor ShareholderBuy300,000$5.76$1,728,000.00  
12/17/2024G. Walmsley GrahamDirectorSell700,761$6.75$4,730,136.75  
12/10/2024Cyrus HarmonDirectorSell8,256$9.37$77,358.72  
12/10/2024David C MylesInsiderSell12,452$9.38$116,799.76  
12/10/2024Sean BohenCEOSell52,328$9.37$490,313.36  
(Data available from 1/1/2013 forward)

OLMA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Olema Pharmaceuticals includes Bain Capital Life Sciences Inv, Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Naseem Zojwalla, and Sean Bohen. Learn more on insiders at OLMA.

16.36% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings.

The following insiders have purchased OLMA shares in the last 24 months: Bain Capital Life Sciences Inv ($1,728,000.00), Biocapital Advisors L Paradigm ($1,160,000.00), Bvf Partners L P/Il ($14,818,370.88), and G. Walmsley Graham ($1,871,235.30).

Insiders have purchased a total of 2,037,802 OLMA shares in the last 24 months for a total of $19,577,606.18 bought.

The following insiders have sold OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($35,784,000.00), Cyrus Harmon ($2,968,700.12), David C Myles ($483,348.03), G. Walmsley Graham ($4,730,136.75), Naseem Zojwalla ($110,721.24), and Sean Bohen ($926,193.20).

Insiders have sold a total of 3,486,218 Olema Pharmaceuticals shares in the last 24 months for a total of $45,003,099.34 sold.

Olema Pharmaceuticals Key Executives

  • Dr. Sean P. Bohen M.D. (Age 57)
    Ph.D., President, CEO & Director
    Compensation: $1.15M
  • Mr. Shane William Charles Kovacs M.B.A. (Age 50)
    Chief Operating & Financial Officer
    Compensation: $820.37k
  • Dr. Naseem Zojwalla M.D. (Age 51)
    Chief Medical Officer
    Compensation: $753.37k
  • Ms. Julie Dexter
    Senior VP & Head of People
  • Dr. David C. Myles Ph.D. (Age 61)
    Chief Discovery & Non-Clinical Development Officer
    Compensation: $200k
  • Ms. Demiana Faltaos Ph.D.
    Pharm.D., VP & Head of Clinical Pharmacology
  • Mr. John B. Moriarty Jr. (Age 56)
    ESQ., J.D., Corporate Secretary
    Compensation: $434.32k
  • Ms. Sasha Austin CPA
    VP of Finance & Controller

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:OLMA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel